The Director, Value & Evidence – Breast Cancer (BC), CDK4 Lead will support the strategic goals of the Oncology Business Unit (BU) by driving optimal patient access though evidence generation and partnership with cross-functional colleagues. This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal patient access by demonstrating the value of Pfizer’s CDK4 asset within the framework of the BC Franchise. The Value & Evidence Director will be responsible for developing and executing against the global evidence generation strategy, including direct oversight of evidence generation activities and dissemination of technical deliverables ROLE RESPONSIBILITIES • Lead the development of the evidence generation strategy to support the value of Pfizer’s CDK4 asset within the framework of the BC Franchise, in close partnership with the cross-functional matrix team. • Lead the coordination of input from local country/regional teams on evidence needs and ensure that the input is appropriately incorporated to develop and integrate the evidence strategy to support global market access needs at launch and through lifecycle. • Lead the timely development of launch deliverables including early global value dossiers, evidence blueprints, systematic literature reviews, economic models, and innovative tools to successfully support reimbursement and access requirements in conjunction with the regions/countries. • Lead the design and execution of global HEOR studies (eg, network meta-analyses, non-interventional studies) from concept through publication. • Incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence aligned with overall asset strategy and to ensure global reimbursement and access requirements. • Provide strategic input into clinical trial designs (eg, patient populations, comparators, endpoints) to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers. • Partner with internal stakeholders to ensure appropriate customer facing dissemination of HEOR materials per regulatory guidance and internal SOPs. • Partner with other Value and Evidence breast cancer colleagues to ensure strategic alignment and successful/timely execution of BC-specific projects • Develop strategic partnerships and research collaborations with key external experts, healthcare policy makers, payers, and various academic and community oncology settings to support asset strategies.